Celltrion Stock price
Compare with Peer Group
Is Celltrion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.
Key metrics
Celltrion Stock Analysis
Analyst Opinions
30 Analysts have issued a Celltrion forecast:
Analyst Opinions
30 Analysts have issued a Celltrion forecast:
Don't miss a Thing! We will send you all news about Celltrion directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Celltrion, Inc. engages in the development, manufacture and distribution of pharmaceuticals. It operates through the Biopharmaceuticals, Chemical Drugs and Others businesses. Its products include remsima and biosimilars. The company was founded on February 27, 1991 and is headquartered in Incheon, South Korea.
| Head office | South Korea |
| CEO | Mr. Gi |
| Employees | 2,680 |
| Founded | 1991 |
| Website | www.celltrion.com |


